Command Palette

Search for a command to run...

prism-medico-and-pharmacy

22.34+4.93%
Market Cap
₹12.91 Cr
Stock P/E
321.12
ROCE
0.07%
ROE
0.31%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Prism Medico and Pharmacy Ltd. operates in a competitive finance investment sector, where its financial metrics indicate significant underperformance compared to its peers. Companies like Authum Investment & Infrastructure Ltd. and Bajaj Finserv Ltd. stand out for their robust profitability and growth, while Prism’s negative PE and low revenue growth highlight its struggles. Therefore, it is crucial to consider the strengths of the sector leaders while assessing investment strategies.

Key Points
  • Prism Medico shows stagnant growth with 0% revenue growth YoY and a negative PE ratio.
  • Authum Investment & Infrastructure Ltd. leads in profitability metrics with an ROE of 33.88% and a low debt-equity ratio.
  • Bajaj Finserv Ltd. has shown strong revenue growth of 21.23% YoY and a solid EPS growth, indicating strong market positioning.
Top Performers
Authum Investment & Infrastructure Ltd.

Highest ROE (33.88%) and low debt-equity ratio (0.0718), indicating strong profitability and low financial risk.

Bajaj Finserv Ltd.

Strong revenue growth (21.23% YoY) and robust profitability metrics (ROE of 29.52%) make it a standout performer.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.